Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Nobuhiro, Tahara"'
Autor:
Yuichi Tamura, Rika Takeyasu, Tomohiro Takata, Naoki Miyazaki, Ryo Takemura, Michihiko Wada, Yudai Tamura, Kohtaro Abe, Ayako Shigeta, Yu Taniguchi, Shiro Adachi, Takumi Inami, Ichizo Tsujino, Nobuhiro Tahara, Masataka Kuwana
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Pulmonary arterial hypertension (PAH), an intractable disease with a poor prognosis, is commonly treated using pulmonary vasodilators modulating the endothelin, cGMP, and prostacyclin pathway. Since the 2010s, drugs for treating pulmonary hy
Externí odkaz:
https://doaj.org/article/ae1a1d1504564724897608808e687b14
Autor:
Nobuhiro Tahara, Olivier Lairez, Jin Endo, Atsushi Okada, Mitsuharu Ueda, Tomonori Ishii, Yoshinobu Kitano, Hahn‐Ey Lee, Eleonora Russo, Toru Kubo
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 251-262 (2022)
Abstract Transthyretin amyloid cardiomyopathy (ATTR‐CM) is caused by the cardiac deposition of insoluble amyloid fibrils formed by misfolded transthyretin proteins and is associated with various cardiac symptoms, such as progressive heart failure,
Externí odkaz:
https://doaj.org/article/98cc813d072b4159b66ec3db8e04be61
Autor:
Masataka Kuwana, Kohtaro Abe, Hideyuki Kinoshita, Hiromi Matsubara, Shun Minatsuki, Toyoaki Murohara, Seiichiro Sakao, Yuichiro Shirai, Nobuhiro Tahara, Ichizo Tsujino, Kenta Takahashi, Shingo Kanda, Takeshi Ogo
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract Treprostinil is a chemically stable analog of prostacyclin, and inhaled treprostinil was developed to deliver the effects directly to the pulmonary vasculature while minimizing systemic side effects. The objective of the study was to evaluat
Externí odkaz:
https://doaj.org/article/f67bff0638ba4ce581c356caf2c9e7e2
Autor:
Takayuki Inomata, Nobuhiro Tahara, Kazufumi Nakamura, Jin Endo, Mitsuharu Ueda, Tomonori Ishii, Yoshinobu Kitano, Jun Koyama
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2647-2659 (2021)
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is caused by the deposition of wild‐type transthyretin (TTR) amyloid fibrils in the heart. The age at diagnosis of ATTRwt‐CM is reported to be approximately 70–80 years, an
Externí odkaz:
https://doaj.org/article/0d7c487ccdff42b6959d0790682fc73c
Autor:
Tatsuya Maruhashi, Yukihito Higashi, Hisako Yoshida, Atsushi Tanaka, Kazuo Eguchi, Hirofumi Tomiyama, Kazuomi Kario, Toru Kato, Nozomu Oda, Nobuhiro Tahara, Mitsutoshi Oguri, Hirotaka Watada, Koichi Node
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundXanthine oxidase is involved in the production of uric acid and the generation of superoxide anion. We evaluated the long-term effect of febuxostat, a non-purine selective xanthine oxidase inhibitor, on endothelial function in patients with
Externí odkaz:
https://doaj.org/article/5c4cd3f06f6c47798ecee9c3619ead53
Publikováno v:
BMJ Case Reports; Sep2024, Vol. 17 Issue 9, p1-3, 3p
Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
Autor:
Kosuke Saku, Nobuhiro Tahara, Tohru Takaseya, Hiroyuki Otsuka, Kazuyoshi Takagi, Takahiro Shojima, Yusuke Shintani, Yasuyuki Zaima, Satoshi Kikusaki, Tomofumi Fukuda, Atsunobu Oryoji, Yuri Nishino, Takanori Matsui, Tatsuyuki Kakuma, Jun Akiba, Yoshihiro Fukumoto, Sho‐ichi Yamagishi, Hiroyuki Tanaka
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 13 (2020)
Background Aortic stenosis (AS) is highly prevalent in patients with atherosclerotic cardiovascular disease. Advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) play a pivotal role for vascular calcification in atherosclerosis. We
Externí odkaz:
https://doaj.org/article/55d1b16414c747f9be53b31b64e77d20
Autor:
Kohei Ishibashi, Yoshinobu Eishi, Nobuhiro Tahara, Masanori Asakura, Naka Sakamoto, Kazufumi Nakamura, Yoichi Takaya, Tomohisa Nakamura, Yoshikazu Yazaki, Tetsuo Yamaguchi, Koko Asakura, Toshihisa Anzai, Teruo Noguchi, Satoshi Yasuda, Fumio Terasaki, Toshimitsu Hamasaki, Kengo Kusano
Publikováno v:
Journal of Arrhythmia, Vol 34, Iss 5, Pp 520-526 (2018)
Abstract Background Cardiac sarcoidosis (CS) is a noncaseating granulomatous disease of unknown etiology. Lifelong immunosuppressive therapy, most frequently using corticosteroids, is a standard therapy to control hypersensitivity of immune reactions
Externí odkaz:
https://doaj.org/article/e1b4936c82794af1ad893e1b730fb07f
Autor:
Kenji Suda, Nobuhiro Tahara, Munehisa Bekki, Tomohisa Nakamura, Akihiro Honda, Shintaro Kishimoto, Yoshiyuki Kagiyama, Motofumi Iemura, Kiminori Fujimoto, Toshi Abe, Yoshihiro Fukumoto
Publikováno v:
Journal of Nuclear Cardiology. 30:264-275
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2967e14fafa8fb413c9ceb7ad4cbb8d
https://doi.org/10.1007/s12350-022-03041-1
https://doi.org/10.1007/s12350-022-03041-1
Autor:
Hidetoshi Chibana, Nobuhiro Tahara, Naoki Itaya, Takashi Ishimatsu, Masahiro Sasaki, Motoki Sasaki, Takaharu Nakayoshi, Masanori Ohtsuka, Shinji Yokoyama, Ken-ichiro Sasaki, Takafumi Ueno, Yoshihiro Fukumoto
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 17, Iss C, Pp 30-32 (2017)
Background: Unresolved thromboemboli in the pulmonary arteries (PA) is known to cause chronic thromboembolic pulmonary hypertension (CTEPH). However, it remains unknown if vascular dysfunction in pulmonary arteries exists in patients with CTEPH. Meth
Externí odkaz:
https://doaj.org/article/8e822023e5a64912a408ef3bc885a052